Business Description
Biohaven Pharmaceutical Holding Co Ltd
NAICS : 325412
SIC : 2834
ISIN : VGG111961055
Description
Biohaven Pharmaceutical Holding Co Ltd is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV-3100, BHV5000, BHV5500, among others.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.72 | |||||
| Equity-to-Asset | -0.58 | |||||
| Debt-to-Equity | -0.96 | |||||
| Debt-to-EBITDA | -1.06 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | -3.63 | |||||
| Beneish M-Score | -0.86 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -22 | |||||
| 3-Year EPS without NRI Growth Rate | -28.6 | |||||
| 3-Year FCF Growth Rate | -35.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 25.84 | |||||
| 12-1 Month Momentum % | 2.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.75 | |||||
| Quick Ratio | 1.59 | |||||
| Cash Ratio | 0.82 | |||||
| Days Inventory | 246.61 | |||||
| Days Sales Outstanding | 119.79 | |||||
| Days Payable | 166.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.8 | |||||
| Shareholder Yield % | -3.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.63 | |||||
| Operating Margin % | -74.44 | |||||
| Net Margin % | -108.04 | |||||
| FCF Margin % | -71.37 | |||||
| ROA % | -79.9 | |||||
| ROIC % | -223.85 | |||||
| ROC (Joel Greenblatt) % | -5651.99 | |||||
| ROCE % | -118.17 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.13 | |||||
| EV-to-EBIT | -14.81 | |||||
| EV-to-Forward-EBIT | 381.92 | |||||
| EV-to-EBITDA | -15.28 | |||||
| EV-to-Forward-EBITDA | -28.65 | |||||
| EV-to-Revenue | 12.9 | |||||
| EV-to-Forward-Revenue | 9.01 | |||||
| EV-to-FCF | -18.07 | |||||
| Earnings Yield (Greenblatt) % | -6.75 | |||||
| FCF Yield % | -5.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BHVN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biohaven Pharmaceutical Holding Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 859.684 | ||
| EPS (TTM) ($) | -14.82 | ||
| Beta | 0 | ||
| Volatility % | 76.64 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0.628929 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 2.66 | ||
| 52-Week Range ($) | 79.01 - 152.56 | ||
| Shares Outstanding (Mil) | 71.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biohaven Pharmaceutical Holding Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biohaven Pharmaceutical Holding Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biohaven Pharmaceutical Holding Co Ltd Frequently Asked Questions
What is Biohaven Pharmaceutical Holding Co Ltd(BHVN)'s stock price today?
The current price of BHVN is $14.08. The 52 week high of BHVN is $152.56 and 52 week low is $79.01.
When is next earnings date of Biohaven Pharmaceutical Holding Co Ltd(BHVN)?
The next earnings date of Biohaven Pharmaceutical Holding Co Ltd(BHVN) is .
Does Biohaven Pharmaceutical Holding Co Ltd(BHVN) pay dividends? If so, how much?
Biohaven Pharmaceutical Holding Co Ltd(BHVN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers